Pediatric Home Health Agency Valuation in 2026: A Complete Guide

Pediatric home health and pediatric private duty nursing (PDN) sit in one of the most attractive corners of home-based care M&A. Buyers consistently pay premium multiples for quality pediatric platforms — often 6× to 9× EBITDA, with the best assets reaching higher — yet many pediatric agency owners underestimate what their business is worth in the current market.

This guide explains why pediatric agencies trade at a premium, how buyers actually evaluate them, and what separates a good outcome from a great one.

---

Why Pediatric Commands Premium Multiples

Three structural factors drive valuations.

1. Clinical Complexity and Per-Case Revenue

Pediatric home health serves medically fragile children — ventilator-dependent, tracheostomy, complex feeding, congenital and neurological conditions, post-NICU graduates. The clinical intensity translates into higher authorized hours per patient, higher nursing skill requirements, and higher reimbursement rates than typical adult skilled or non-medical home care.

A typical pediatric PDN patient receives 40 to 80+ authorized hours per week, often for years rather than episodes. Per-patient annual revenue commonly runs $80,000 to $200,000+ — multiples higher than adult Medicare home health episodes or non-medical personal care cases.

2. Length of Service and Revenue Predictability

Adult Medicare home health revenue is episodic — 60-day periods with discharge as the goal. Pediatric PDN revenue is the opposite. Many patients remain on service for years, often through transitions to school-based care or until adulthood. Census stability is structurally higher than nearly any other segment of home-based care, which buyers reward through both higher multiples and lower diligence-related discounts.

3. Workforce Scarcity

Pediatric-trained RNs and LPNs are a chronic supply constraint. The clinical training, comfort with medically complex children, and parent-facing communication skills cannot be created on demand. Agencies with strong nurse recruiting, retention, and training infrastructure have a moat that buyers pay for.

---

Pediatric Valuation Multiples in 2026

Multiples vary by EBITDA scale, clinical complexity, payer mix, and geographic positioning.

Agency Profile	EBITDA Range	Typical Multiple
Sub-scale pediatric PDN (single state, $300K–$750K EBITDA)	$300K–$750K	4.0× – 5.5×
Mid-market pediatric PDN ($750K–$2M EBITDA)	$750K–$2M	5.5× – 7.0×
Multi-state pediatric platform ($2M–$5M EBITDA)	$2M–$5M	6.5× – 8.5×
Large pediatric platform with complex care depth ($5M+ EBITDA)	$5M+	7.5× – 9.5×+

These multiples reflect the median quality agency. Premium drivers (geographic density, clinical complexity capability, nurse retention, payer rate strength) push toward the top of the range. Discount drivers (single-payer concentration, weak nurse retention, geographic sprawl) push toward the bottom or below.

---

What Buyers Actually Look For

Authorized Hours Fill Rate

The single most important pediatric KPI in diligence. Buyers ask: of the hours that have been authorized by the payer for your existing patient population, what percentage are you actually staffing? An agency with $5M of authorized but unstaffed hours per year is sitting on enormous unrealized revenue — and a buyer with stronger recruiting infrastructure will model the upside and pay for it.

Fill rates above 90% are exceptional and command premium attention. Fill rates below 70% suggest staffing constraints that the buyer will scrutinize hard but may also see as upside opportunity.

Nurse Recruiting and Retention Metrics

Buyers will review:

• Annual nurse turnover rate (industry benchmark 30–50%; under 25% is exceptional)
• Average nurse tenure
• Time-to-fill for new shifts
• Recruiting pipeline volume and conversion rate
• New nurse training program structure
• Wage benchmarking vs. local market

Agencies with documented retention infrastructure — competitive wages, benefits, scheduling flexibility, clinical mentorship — command premium multiples because the buyer is acquiring durable staffing capacity rather than a roster that may walk after close.

Payer Mix and Rate Structure

Pediatric agencies typically operate across:

• Medicaid EPSDT — the largest payer for most pediatric PDN; rates vary significantly by state
• Medicaid Managed Care (MCO contracts) — increasing share of Medicaid revenue in many states
• State waivers for medically complex children
• Commercial insurance for complex cases (smaller share, often higher rates)
• CCS / Title V programs in some states

Rate adequacy by state and by program is a major valuation variable. Operating in states with strong pediatric PDN rates (and credible rate-setting transparency) supports premium multiples.

Clinical Complexity Mix

Buyers look at the acuity profile of your census. An agency serving primarily lower-acuity patients (basic skilled nursing, simple medication administration) is valued differently from an agency with depth in vent/trach, complex feeding, and neurological care. Higher-acuity agencies command premiums because:

• Per-case revenue is higher
• Length of service is longer
• Competition for these patients is lower
• The clinical reputation generates referral tailwinds

Geographic Density

Pediatric PDN is a logistics-intensive business. Density in a metro area allows for shift coverage, nurse cross-coverage, and operational efficiency that geographic sprawl destroys. A pediatric agency with $3M EBITDA concentrated in two metro areas is more valuable per dollar of EBITDA than $3M EBITDA spread across eight states.

Referral Source Diversification

Buyers want diversification across:

• Children’s hospital systems (NICU, PICU discharge planners)
• Pediatric specialty practices (pulmonology, GI, neurology)
• Schools and early intervention programs
• Medicaid case management organizations
• Family direct inquiries

Agencies with single-source dependence (e.g., 60%+ of new admissions from one hospital) face referral concentration discounts.

---

Segment-Specific Considerations

Pediatric PDN (Private Duty Nursing)

The largest pediatric home-based care segment by both revenue and M&A volume. PDN agencies bill Medicaid (and select commercial) for authorized hours of skilled nursing care. Valuation centers on hours-based metrics: authorized hours, fill rate, billable hour conversion, and nurse productivity.

Pediatric Medicare-Certified Home Health

A smaller but specialized segment serving children with skilled care needs under Medicare Part A or under state Medicaid plans that cover pediatric home health visits. OASIS, plan of care, and 60-day episode mechanics apply. Valuations are influenced by case mix index, LUPA rates, and survey performance similar to adult Medicare home health.

Pediatric Therapy (PT, OT, Speech)

Often delivered alongside PDN or as a standalone line, pediatric therapy services generate steady revenue with high margins. Buyers value pediatric therapy practices on therapist productivity, payer mix (Medicaid, commercial, school district contracts), and waitlist depth as a proxy for unmet demand.

Behavioral and Developmental Services

Pediatric agencies that have integrated ABA, behavioral health, or developmental disability services trade in a different valuation framework. ABA in particular has its own M&A market and multiples (covered separately). Buyers may value the combined platform at a blended rate or carve out the ABA economics.

---

Common Diligence Issues That Compress Pediatric Valuations

1. Unstaffed authorized hours not properly disclosed — buyers find this fast and will discount aggressively if not transparent upfront.
2. Nurse misclassification (1099 vs W-2) — pediatric agencies that have used 1099 nursing carry a real risk; buyers will require reclassification and assess back-tax exposure.
3. Plan of care and physician order documentation gaps — Medicaid audits in pediatric PDN are common, and documentation weakness creates payer recoupment risk.
4. Concentration in a single MCO — if 60%+ of revenue flows through one Medicaid managed care contract, the buyer is underwriting MCO renewal risk and will discount.
5. EVV compliance gaps — pediatric PDN is subject to EVV requirements; gaps create both compliance and billing risk.
6. Owner-operator clinical involvement — if the founder is the de facto Director of Nursing, buyers will model the cost of replacing that role and discount accordingly.

---

Strategic Implications for Pediatric Agency Owners

If You Are Considering a Sale in the Next 12–24 Months

The pediatric M&A market is strong, and 2026 is a favorable selling environment. Priorities:

• Get your authorized-hours fill rate measured and documented
• Clean up nurse classification and credentialing files
• Diversify referral sources to reduce concentration risk
• Document your clinical training and complexity-care capabilities
• Get a current valuation from an advisor experienced in pediatric M&A specifically

If You Have a Longer Horizon

Pediatric is one of the rare home-based care segments where investment in quality directly translates to multiple expansion at exit. Prioritize:

• Building a recruiting and retention infrastructure that keeps nurse turnover under 25%
• Geographic concentration in 2–3 metros with strong pediatric demand
• Capability investment in vent/trach and complex care
• Clinical leadership depth (Director of Nursing not dependent on the owner)
• Multi-payer contracting beyond your dominant Medicaid MCO

---

The Buyer Landscape

Active acquirers in pediatric home-based care include:

• PE-backed pediatric platforms building multi-state pediatric PDN and home health businesses
• Adult home care platforms expanding into pediatric as a complementary service line
• Children’s hospital health systems acquiring pediatric home care to extend the continuum
• National pediatric specialty companies rolling up regional providers

Different buyer types value different things. A children’s hospital strategic buyer may pay premium for clinical reputation and complex care depth in their service area. A PE platform may pay premium for scale, payer diversification, and geographic fit with their existing footprint.

---

The pediatric home health and PDN market in 2026 rewards quality operators with premium multiples that have remained resilient even as other segments faced multiple compression. The combination of clinical complexity, length of service stability, payer rate strength, and workforce scarcity creates a defensible economic profile that sophisticated buyers actively pay for.

If you would like to discuss what your pediatric agency could realistically command in today’s market, contact us for a confidential conversation.